Overview

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety data of darunavir in a natural clinical practice.
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Darunavir